US 11713313
GLS1 inhibitors for treating disease
granted A61KA61K31/4439A61K31/454
Quick answer
US patent 11713313 (GLS1 inhibitors for treating disease) held by The Board of Regents of the University of Texas System expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4439, A61K31/454, A61K31/4545, A61K31/501